Occam ’s Razor and COVID-19 Hospitalization Rates
By JASON Z. ROSE
It’s amazing that the word “medication” is not mentioned in a recent Morbidity and Mortality Weekly Report from the US Centers for Disease Control and Prevention (CDC). The research states that a staggering 90% of people hospitalized for COVID-19 have underlying conditions, including hypertension, diabetes mellitus and cardiovascular disease, all of which require drug treatments for patients to remain healthy.
Yet nowhere in the report is there mention of how
patients can potentially prevent COVID-19 related health decline through better
medication use for their underlying disease.
Are the COVID-19 hospitalization rates truly caused by the underlying
disease and insufficient use of preventive measures like social distancing? Or
are these underlying conditions unmanaged due to medication optimization issues
placing these patients at higher risk for hospitalizations?
Medication optimization is how the healthcare system
supports the patient from the initial prescription to follow up and ongoing
review. It aims to improve the safety, effectiveness, and affordable use of
prescribed drugs.
The invisible threat enabling the spread of COVID-19
that no one seems to be talking about is that barriers to medication use are
accelerating infections for these high-risk populations. Buried within the “People Who Need Extra Precautions”
section of its website, the CDC states people with high-risk for severe illness
from COVID-1...
Source: The Health Care Blog - Category: Consumer Health News Authors: Christina Liu Tags: COVID-19 Health Policy adhere health covid-19 hospitalization rates jason rose Source Type: blogs
More News: Blogging | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Centers for Disease Control and Prevention (CDC) | COVID-19 | Diabetes | Diabetes Mellitus | Disability | Endocrinology | Genetics | Health | Health Management | Heart | Heart Disease | Hypertension | Medicaid | Men | Study | Unemployment | Websites